Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-Approval Study of Asfotase Alfa for HPP in Japan
NCT02531867Phase 4Completed
- Sponsor
- Alexion Pharmaceuticals
- Start
- Jun 2015
- Primary completion
- Nov 2015
- Modality
- Replacement Enzymes
01
Overview
A Phase 4 trial of asfotase alfa in hypophosphatasia (HPP), sponsored by Alexion Pharmaceuticals. Started Jun 2015; status: completed.
02
Drugs
asfotase alfa
03
Conditions
hypophosphatasia (HPP)
Beyond the preview
Go deeper on NCT02531867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02531867.